ライフサイエンスコーパス: diabetes insipidus

1 ible with a diagnosis of partial nephrogenic diabetes insipidus.

2 ndling of water in health and in nephrogenic diabetes insipidus.

3 might be necessary in patients with central diabetes insipidus.

4 in AVP-expressing neurons, developed central diabetes insipidus.

5 treatment of mice and a patient with central diabetes insipidus.

6 a (increased water intake), both features of diabetes insipidus.

7 autoreactive CD8 T cells can trigger central diabetes insipidus.

8 ing, the absence of which causes nephrogenic diabetes insipidus.

9 s a potential therapeutic use in nephrogenic diabetes insipidus.

10 main of the human vasopressin gene can cause diabetes insipidus.

11 defect and hypernatremic dehydration due to diabetes insipidus.

12 essin analog), characteristic of nephrogenic diabetes insipidus.

13 alleles responsible for X-linked nephrogenic diabetes insipidus.

14 ing from congenital cataracts to nephrogenic diabetes insipidus.

15 mice produces distinct forms of nephrogenic diabetes insipidus.

16 he pathogenesis of familial neurohypophyseal diabetes insipidus.

17 t tissue and nodal involvement, and four had diabetes insipidus.

18 another three patients due to development of diabetes insipidus.

19 ions or downregulation can cause nephrogenic diabetes insipidus.

20 a, twins or triplets, or subclinical central diabetes insipidus, a transient diabetes insipidus may e

21 Autosomal dominant familial neurohypophyseal diabetes insipidus (adFNDI) is a progressive, inherited

22 autosomal dominant familial neurohypophyseal diabetes insipidus (adFNDI), a rare inherited disorder t

23 effect of donor hyperosmolarity secondary to diabetes insipidus, an almost universal occurrence among

24 e an autosomal recessive form of nephrogenic diabetes insipidus and absence of the Colton blood group

25 mutations in aquaporins include nephrogenic diabetes insipidus and congenital cataracts.

26 re renal side effects, including nephrogenic diabetes insipidus and rarely, ESRD.

27 ts identify a novel mechanism of nephrogenic diabetes insipidus and uncover a role of SOCE in renal w

28 icant risk factor for lower scores, but sex, diabetes insipidus, and cranial radiotherapy were not.

29 eases such as Gaucher's disease, nephrogenic diabetes insipidus, and Creutzfeldt-Jakob disease.

30 enerative origin of optic atrophy, deafness, diabetes insipidus, and incontinence, (2) other previous

31 dentified growth hormone deficiency, central diabetes insipidus, and male hypogonadism as new feature

32 Improvement in bone lesions, pain, diabetes insipidus, and other manifestations was gradual

33 function, including hypochloremic alkalosis, diabetes insipidus, and salt-sensitive hypotension, with

34 attleboro rats, with hereditary hypothalamic diabetes insipidus, and Sprague-Dawley rats, with normal

35 Fourteen months post-OLT she developed diabetes insipidus, bilateral ear discharge, and new ost

36 ed with several disorders, including central diabetes insipidus (CDI).

37 Furthermore, in a patient with central diabetes insipidus, desmopressin reduced the excretion o

38 Unexpectedly, diabetes insipidus developed in surviving animals.

39 X receptor beta (LXRbeta) in the etiology of diabetes insipidus (DI).

40 eatures subsequently emerged, and "DIDMOAD" (diabetes insipidus, diabetes mellitus, optic atrophy, an

41 ble organ donors without clinically apparent diabetes insipidus display a defect in the baroreflex-me

42 tis pigmentosa, color blindness, nephrogenic diabetes insipidus, familial ACTH resistance, and famili

43 Familial neurohypophyseal diabetes insipidus (FNDI) in humans is an autosomal domi

44 Familial neurohypophyseal diabetes insipidus (FNDI) is an autosomal dominant disor

45 autosomal dominant familial neurohypophyseal diabetes insipidus (FNDI).

46 nent damage by the primary disease, LCH (eg, diabetes insipidus, fractures, and tooth loss).

47 veloped as the disease progressed, including diabetes insipidus, growth hormone deficiency, primary h

48 nt inhibitor of GSK3beta, causes nephrogenic diabetes insipidus, GSK3beta may play a crucial role in

49 2 receptor and aquaporin 2 cause nephrogenic diabetes insipidus; however, expression of these genes i

50 ascular complications, visual complications, diabetes insipidus, hypopituitarism and cranial nerve in

51 etal defects in 42%, dental problems in 30%, diabetes insipidus in 25%, growth failure in 20%, sex ho

52 Other features included nephrogenic diabetes insipidus in 87% and hypertension in 33.3%.

53 d distal tubular toxicity caused nephrogenic diabetes insipidus in one.

54 hich is associated with familial nephrogenic diabetes insipidus, induces constitutive arrestin-mediat

55 most common cause of hereditary nephrogenic diabetes insipidus is a nonfunctional vasopressin (VP) r

56 Familial neurohypophyseal diabetes insipidus is an autosomal dominant disorder cha

57 Autosomal dominant familial neurohypophyseal diabetes insipidus is caused by mutations in the arginin

58 Postoperative diabetes insipidus is common after pituitary surgery and

59 This nephrogenic diabetes insipidus leads to dehydration and death of nur

60 ver, proAVP misfolding in hereditary central diabetes insipidus likely shares common physiopathologic

61 To reduce lithium-induced nephrogenic diabetes insipidus (lithium-NDI), patients with bipolar

62 erimental iron overload leads to nephrogenic diabetes insipidus marked by AVP-resistant urinary conce

63 ical central diabetes insipidus, a transient diabetes insipidus may ensue from this vasopressinase-me

64 Mechanisms underlying the pathogenicity of diabetes insipidus mutations were probed by studying the

65 (AQP2) point mutants that cause nephrogenic diabetes insipidus (NDI) are retained in the endoplasmic

66 Congenital nephrogenic diabetes insipidus (NDI) is a rare disease caused most o

67 Nephrogenic diabetes insipidus (NDI) is caused by impairment of vaso

68 Hereditary non-X-linked nephrogenic diabetes insipidus (NDI) is caused by mutations in the a

69 n family with partial congenital nephrogenic diabetes insipidus (NDI) that resulted from a mutation i

70 utations that cause non-X-linked nephrogenic diabetes insipidus (NDI) were characterized to establish

71 nts treated with lithium develop nephrogenic diabetes insipidus (NDI), a disorder characterized by po

72 ary concentrating ability, i.e., nephrogenic diabetes insipidus (NDI), but the molecular mechanism is

73 ting a transgenic mouse model of nephrogenic diabetes insipidus (NDI), we have analyzed the mouse aqu

74 defective trafficking results in nephrogenic diabetes insipidus (NDI).

75 can produce autosomal recessive nephrogenic diabetes insipidus (NDI).

76 re of the possibility of sevoflurane-induced diabetes insipidus not only during general anesthesia bu

77 lex, followed by a hyperdynamic response and diabetes insipidus, occurred in every animal following b

78 ore is the treatment of choice for transient diabetes insipidus of pregnancy.

79 Our findings establish a form of nephrogenic diabetes insipidus produced by impaired water permeabili

80 with these effects, Grhl2-deficient mice had diabetes insipidus, produced dilute urine, and failed to

81 associated with Charcot-Marie-Tooth disease, diabetes insipidus, retinitis pigmentosa, cystic fibrosi

82 He was later diagnosed with diabetes insipidus, spastic quadriplegia, developmental

83 hree children affected with neurohypophyseal diabetes insipidus, suggesting autosomal recessive inher

84 The nephrogenic diabetes insipidus symptoms and the absence of developme

85 (AdAVP) in an AVP-deficient animal model of diabetes insipidus (the Brattleboro rat), which allowed

86 that a molecular determinant for nephrogenic diabetes insipidus, the vasopressin receptor with a subs

87 id organ donors without clinical evidence of diabetes insipidus; we also investigated the vasopressor

88 shing phenomenon, hyperdynamic response, and diabetes insipidus were observed in each animal after BD

89 n to be responsible for X-linked nephrogenic diabetes insipidus were used as model systems.

90 hormone arginine vasopressin (AVP) underlies diabetes insipidus, which is characterized by the excret

91 -) mice represent a new model of nephrogenic diabetes insipidus with unique molecular etiology, and w

92 mutation known to cause X-linked nephrogenic diabetes insipidus (XNDI) in humans (Glu242stop) into th

93 X-linked nephrogenic diabetes insipidus (XNDI) is a severe kidney disease cau